RE: New share issue likelyIf the E.coli vaccine approval is a certainty and only a matter of months away (as some have suggested), why would they not wait until after approval to dilute us? After all, they would get a lot more $$$ for the same number of shares.
Now, if the E.coli vaccine approval is in jeopardy, then now would obviously be a better time to dilute us.
With that said, I really hope they don't dilute us.